Intestinal absorption mechanisms of berberine, palmatine, jateorhizine, and coptisine: involvement of P-glycoprotein

References

• Artursson P, Karlsson J. (1991). Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun 175:880–885.
   PubMed Web of Science ®Google Scholar
• Bailey CA, Bryla P, Malick AW. (1996). The use of the intestinal epithelial cell culture model, Caco-2, in pharmaceutical development. Adv Drug Deliv Rev 22:85–103.
   Web of Science ®Google Scholar
• Chinese Pharmacopoeia Commission. (2010). Pharmacopoeia of the People’s Republic of China. Volume I (in Chinese). Beijing, China: Chinese Medicinal Science and Technology Press.
   Google Scholar
• Cordon-Cardo C, O’Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR. (1989). Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood–brain barrier sites. Proc Natl Acad Sci USA 86:695–698.
   PubMed Web of Science ®Google Scholar
• Hayashi K, Minoda K, Nagaoka Y, Hayashi T, Uesato S. (2007). Antiviral activity of berberine and related compounds against human cytomegalovirus. Bioorg Med Chem Lett 17:1562–1564.
   PubMed Web of Science ®Google Scholar
• Inoue K, Kulsum U, Chowdhury SA, Fujisawa S, Ishihara M, Yokoe I, Sakagami H. (2005). Tumor-specific cytotoxicity and apoptosis-inducing activity of berberines. Anticancer Res 25:4053–4059.
   PubMed Web of Science ®Google Scholar
• Jia F, Zou G, Fan J, Yuan Z. (2010). Identification of palmatine as an inhibitor of West Nile virus. Arch Virol 155:1325–1329.
   PubMed Web of Science ®Google Scholar
• Kong LD, Cheng CH, Tan RX. (2001). Monoamine oxidase inhibitors from rhizoma of Coptis chinensis. Planta Med 67:74–76.
   PubMed Web of Science ®Google Scholar
• Kuo CL, Chi CW, Liu TY. (2004). The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 203:127–137.
   PubMed Web of Science ®Google Scholar
• Lanvers-Kaminsky C, Nolting DM, Köster J, Schröder A, Sandkötter J, Boos J. (2006). In-vitro toxicity of Ukrain against human Ewing tumor cell lines. Anticancer Drugs 17:1025–1030.
   Google Scholar
• Lee CH, Chen JC, Hsiang CY, Wu SL, Wu HC, Ho TY. (2007). Berberine suppresses inflammatory agents-induced interleukin-1beta and tumor necrosis factor-alpha productions via the inhibition of IkappaB degradation in human lung cells. Pharmacol Res 56:193–201.
   PubMed Web of Science ®Google Scholar
• Lin CC, Kao ST, Chen GW, Ho HC, Chung JG. (2006). Apoptosis of human leukemia HL-60 cells and murine leukemia WEHI-3 cells induced by berberine through the activation of caspase-3. Anticancer Res 26:227–242.
   PubMed Web of Science ®Google Scholar
• Lin JP, Yang JS, Chang NW, Chiu TH, Su CC, Lu KW, Ho YT, Yeh CC, Mei-Dueyang Lin, HJ, Chung JG. (2007). GADD153 mediates berberine-induced apoptosis in human cervical cancer Ca ski cells. Anticancer Res 27:3379–3386.
   Google Scholar
• Liu F, Ng TB. (2000). Antioxidative and free radical scavenging activities of selected medicinal herbs. Life Sci 66:725–735.
   PubMed Web of Science ®Google Scholar
• Maeng HJ, Yoo HJ, Kim IW, Song IS, Chung SJ, Shim CK. (2002). P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers. J Pharm Sci 91:2614–2621.
   PubMed Web of Science ®Google Scholar
• Makhey VD, Guo A, Norris DA, Hu P, Yan J, Sinko PJ. (1998). Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells. Pharm Res 15:1160–1167.
   PubMed Web of Science ®Google Scholar
• Pan GY, Huang ZJ, Wang GJ, Fawcett JP, Liu XD, Zhao XC, Sun JG, Xie YY. (2003). The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption. Planta Med 69:632–636.
   PubMed Web of Science ®Google Scholar
• Pan GY, Wang GJ, Liu XD, Fawcett JP, Xie YY. (2002). The involvement of P-glycoprotein in berberine absorption. Pharmacol Toxicol 91:193–197.
   PubMedGoogle Scholar
• Piyanuch R, Sukhthankar M, Wandee G, Baek SJ. (2007). Berberine, a natural isoquinoline alkaloid, induces NAG-1 and ATF3 expression in human colorectal cancer cells. Cancer Lett 258:230–240.
   PubMed Web of Science ®Google Scholar
• Sack RB, Froehlich JL. (1982). Berberine inhibits intestinal secretory response of Vibrio cholerae and Escherichia coli enterotoxins. Infect Immun 35:471–475.
   PubMed Web of Science ®Google Scholar
• Schinella GR, Tournier HA, Prieto JM, Mordujovich de Buschiazzo P, Ríos JL. (2002). Antioxidant activity of anti-inflammatory plant extracts. Life Sci 70:1023–1033.
   PubMed Web of Science ®Google Scholar
• Seithel A, Karlsson J, Hilgendorf C, Björquist A, Ungell AL. (2006). Variability in mRNA expression of ABC- and SLC-transporters in human intestinal cells: comparison between human segments and Caco-2 cells. Eur J Pharm Sci 28:291–299.
   PubMed Web of Science ®Google Scholar
• Serafim TL, Oliveira PJ, Sardao VA, Perkins E, Parke D, Holy J. (2008). Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line. Cancer Chemother Pharmacol 61:1007–1018.
   PubMed Web of Science ®Google Scholar
• Shen MP, Sun Q, Wang H. (1993). Studies on the intravenous pharmacokinetics and oral absorption of berberine HCl in beagle dogs. Chin Pharmacol Bull 9:64–67.
   Google Scholar
• Taylor CE, Greenough WB 3rd. (1989). Control of diarrheal diseases. Annu Rev Public Health 10:221–244.
   PubMed Web of Science ®Google Scholar
• Turner N, Li JY, Gosby A, To SW, Cheng Z, Miyoshi H, Taketo MM, Cooney GJ, Kraegen EW, James DE, Hu LH, Li J, Ye JM. (2008). Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action. Diabetes 57:1414–1418.
   PubMed Web of Science ®Google Scholar
• USFDA. (2006). Draft Guidance for Industry: Drug Interaction Studies-Study Design, Data Analysis, and Implications for Dosing and Labeling, U.S. Food and Drug Administration Publication.
   Google Scholar
• Varinska L, Mirossay L, Mojzisova G, Mojzis J. (2010). Antiangiogenic effect of selected phytochemicals. Pharmazie 65:57–63.
   Web of Science ®Google Scholar
• Wang S, Zheng Z, Weng Y, Yu Y, Zhang D, Fan W, Dai R, Hu Z. (2004). Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts. Life Sci 74:2467–2478.
   PubMed Web of Science ®Google Scholar
• Xin HW, Wu XC, Li Q, Yu AR, Ulrich Klotz. (2007). Effects of berberine on the transport of P-gp substrates across Caco-2 and L-MDR1 cell monolayers. Chin Pharmacol Bull 23:799–803.
   Google Scholar
• Yan D, Jin C, Xiao XH, Dong XP. (2008). Antimicrobial properties of berberines alkaloids in Coptis chinensis Franch by microcalorimetry. J Biochem Biophys Methods 70:845–849.
   PubMedGoogle Scholar
• Yang HT, Wang GJ. (2003). Transport and uptake characteristics of a new derivative of berberine (CPU-86017) by human intestinal epithelial cell line: Caco-2. Acta Pharmacol Sin 24:1185–1191.
   Google Scholar
• Yin J, Gao Z, Liu D, Liu Z, Ye J. (2008). Berberine improves glucose metabolism through induction of glycolysis. Am J Physiol Endocrinol Metab 294:E148–E156.
   PubMed Web of Science ®Google Scholar
• Yin J, Hu R, Chen M, Tang J, Li F, Yang Y, Chen J. (2002). Effects of berberine on glucose metabolism in vitro. Metab Clin Exp 51:1439–1443.
   PubMed Web of Science ®Google Scholar
• Yu FS, Yang JS, Lin HJ, Yu CS, Tan TW, Lin YT, Lin CC, Lu HF, Chung JG. (2007). Berberine inhibits WEHI-3 leukemia cells in vivo. In Vivo 21:407–412.
   PubMed Web of Science ®Google Scholar
• Yu S, Zhang H, PanJun F, Hong Y, Ren J, Zhu D, and Xu X. (2000). Determination and preliminary studies of metabolism of berberine in human urine after oral administration. Chin J Clin Pharmacol 16:36–39.
   Google Scholar
• Yuan L, Tu D, Ye X, Wu J. (2006). Hypoglycemic and hypocholesterolemic effects of Coptis chinensis franch inflorescence. Plant Foods Hum Nutr 61:139–144.
   PubMed Web of Science ®Google Scholar
• Zhou L, Yang Y, Wang X, Liu S, Shang W, Yuan G, Li F, Tang J, Chen M, Chen J. (2007). Berberine stimulates glucose transport through a mechanism distinct from insulin. Metab Clin Exp 56:405–412.
   PubMed Web of Science ®Google Scholar
• Zuo F, Nakamura N, Akao T, Hattori M. (2006). Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry. Drug Metab Dispos 34:2064–2072.
   PubMed Web of Science ®Google Scholar